[Hepatocellular carcinoma: a multidisciplinary approach].
The treatment of the hepatocellular carcinoma (HCC) is multidisciplinary. Hepatic transplantation offers the best chances of survival for patients with hepatic cirrhosis and HCC. However the indications for transplantation are limited. For patients that do not qualify for liver transplantation, surgical excision and percutaneous ablative treatment can also be curative. Five years survival then reaches 50%. The choice of treatment is based upon the patient's clinical state, the hepatic function and the cancer clinical stage. Follow-up is crucial as recurrences can be treated by following similar algorithms. The efficacy of oncological adjuvant and neoadjuvant treatment is not yet proved.
Tempia-Caliera
Adrien A
AA
Service de chirurgie viscérale, CHUV, 1011 Lausanne. adrien.tempia@hospvd.ch
Ksontini
Riadh
R
Moradpour
Darius
D
Denys
Alban
A
Halkic
Nermin
N
D000465:Algorithms; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D009367:Neoplasm Staging; D010166:Palliative Care; D011379:Prognosis